Phospholipid mediators and MgATPase modulation causes changes in the cardiovascular effects of vasopressin in lithium carbonate-induced polyuric rats

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 26, Issue 4, 2004, Pages 257-262

  Tyagi, Manoj G ^a   Shanthi, M ^a   Keshavan, V ^a   Vikram, G S ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

Blood pressure; Lithium carbonate (Li2CO3); MgATPase; Phospholipids; Polyuria

Indexed keywords

3 [2 [4 (4,4' DIFLUOROBENZHYDRYLIDENE)PIPERIDINO]ETHYL] 2,3 DIHYDRO 2 THIOXO 4(1H) QUINAZOLINONE; ADENOSINE TRIPHOSPHATASE (MAGNESIUM); ARGIPRESSIN; DIACYLGLYCEROL KINASE INHIBITOR; LITHIUM CARBONATE; LYPRESSIN; NEOMYCIN; PHOSPHOLIPASE INHIBITOR; SPHINGOSINE; VASOPRESSIN DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; BRADYCARDIA; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HEART RATE; LOCOMOTION; NONHUMAN; POLYURIA; RAT;

ANIMALS; ARGININE VASOPRESSIN; BLOOD PRESSURE; CA(2+) MG(2+)-ATPASE; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; HEART RATE; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENOUS; LITHIUM CARBONATE; LYSINE VASOPRESSIN; MICE; MOTOR ACTIVITY; NEOMYCIN; PHOSPHOLIPIDS; PIPERIDINES; POLYURIA; QUINAZOLINES; QUINAZOLINONES; RATS; RATS, WISTAR; SPHINGOSINE;

EID: 2642530908     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Pivonello, R., Faggiano, A., Arrichiello, P. et al. Central Diabetes insipidus and heart: Effect of acute arginine vasopressin deficiency and replacement treatment with desmopressin on cardiac performance. Clin Endocrinol 2001, 54: 97-106.
2. Laycock, J.F., Hanoune, J. From vasopressin receptor to water channel: Intracellular traffic, constraint and bypass. J Endocrinol 1998, 159: 361-72.
3. + inhibition of vasopressin sensitive adenylate cyclase in cultured renal epithelial cell. Am J Physiol 1988, 255: F995-1002
4. Bendz, H., Aurell, M. Drug-induced diabetes insipidus: Incidence, prevention and management; Drug safety 1999, 21(6): 449-56.
5. Manji, H.K., Potter, W.Z., Lenox, R.H. Signal transduction pathways. Molecular targets for lithium actions. Arch Gen Psychiatry 1995, 52: 531
6. Thakar, J.H., Lapierre, T.D., Walters, B.G. Erythrocyte membrane sodium-potassium and magnesium ATPase in primary affective disorders. Biol Psychiatry 1985, 20(7): 734-40.
7. 2+ATPase activity in the hypoglycaemic adult rat brain. Z Naturforsch 2001, 56(9-16): 912-4.
8. +) stimulated Mg-ATPase in smooth muscle cells of the sheep's common carotid artery. Acta Biol Med Ger 1976, 35(3-4): 453-63.
9. Cunningham, H.B., Yasaki, P.J., Domingo, R.C. et al. The skeletal muscle transverse molecular Mg-ATPase identity with Mg-ATPase of smooth muscle and brain. Arch Biochem Biophys 1993, 303(1): 32-43.
10. Kang, J.J., Cunningham, B.R., Jacheo Schmidt, C., Hiert, A.M., Sabbadini, R.A., Dahms, A.S. Structural, enzymatic and regulatory properties of the transverse tubular MgATPase and its role as a receptor for diacylglycerol. Ann NY Acad Sci 1990, 603: 530-3.
11. 3 pituitary receptor. FEBS Lett 1994, 356: 215-20.
12. b vasopressin receptor. J Biol Chem 1994, 269: 27088-92.
13. 2 receptor and possible risk to Nephrogenic Diabetes Insipidus. Nature 1992, 357: 336-9.
14. 2+]i responses in neonatal rat cardiomyocytes. J Cardiovasc Pharmacol. 1999, 34: 540-6.
15. 1 Vasopressin receptors; Influence of PI-3 Kinase and gap junction inhibitors. Ind J Exp Biol 2003, 41: 574-80.
16. Tyagi, M.G., Thomas, M. Enhanced cardiovascular reactivity to desmopressin in water restricted rats; facilitatory role of immunosuppression. Methods Find Exp Clin Pharmacol 1999, 21(9): 619-24.
17. 2 receptor mediated effects on locomotor and analgesic activity in mice. Pharmacol Rev Commun 1999, 10(4): 265-70.
18. Carney, S.L., Ray, C., Alastair Gillies, H.B. Mechanism of Lithium induced polyuria in the rat. Kidney Int 1996, 50: 377-83.
19. Laursen, U.B.H. The effects of lithium treatment on the expression of Aquaporin and sodium transporters in the rat kidney. Ph.D. Thesis, University of Aarhus, Denmark 2001, 242-4.
20. Hensen, J., Haenelt, M., Gross, P. Lithium induced polyuria and renal vasopressin receptor density; Nephrol Dial Transplant 1996, 11(4): 622-7.
21. 2+ in human neuroblastoma SH-SY5Y cells. Bipolar Disord 2003, 5(1): 6-13.
22. Hupf, H., Gimm, D., Riegger, G., Schunkert, H. Evidence for a vasopressin system in the rat heart. Circ Res 1994, 84: 365-70.
23. Gardiner, S.M., Bennett, T. Cardiac baroreflex sensitivities in conscious, unrestrained Long Evans and battleboro rats. J Auton Nerv System 1988, 23: 213-9.
24. Bonazzola, P., Egido, P., Marengo, F.D., Savio-Galimberti, E., Ponce-Hornos, J.E. Lithium and KB R7943 effects on mechanics and energetics of rat heart muscle. Acta Physiol Scand 2002, 176: 1-11.
25. Ohanian, J., Heagerty, A.M. The phosphoinositide signalling system and hypertension. Curr Opin Nephrol Hypertens 1992, 1(1): 73-82.
26. 2+) - ATPase through a pathway sensitive to cholera toxin and sphingosine. Eur J Biochem 1999, 263(1): 71-8.
27. Benediksdottir, V.E., Jonsdottir, A.M., Skuladottir, B.H. et al. Sphingosine modulation of cAMP levels and beating rate in heart rate. Fundamental Clin Pharmacol 2002, 16(6): 495-502.
28. 2+ transients of rat cardiac myocytes. Br J Pharmacol 2001, 412(2): 121-6.
29. Dehpour, A.R., Samini, M., Ghafourifar, P., Kyani, H. Inhibition by lithium of neomycin induced release of N-acetyl-beta glucosaminidase in the rat heart. Pharmacol Toxicol 1995, 76(3): 202-5.
30. Ghosh, N., Sabbadini, R., Chatterjee, S. Identification, partial purification, and localization of a neutral sphingomyelinase in rabbit skeletal muscle: Neutral sphingomyelinase in skeletal muscle. Mol Cell Biochem 1998, 189(1-2): 161-8.